Lysergic acid diethylamide for depression — a randomized, double-blind, low dose-controlled phase ii trial

Autor: Müller, F., Zaczek, H., Becker, A.M., Ley, L., Borgwardt, S., Santos de Jesus, J., Loh, N., Kohut, J., Auernig, M., Böhlke, C., Liechti, M.E.
Zdroj: In Neuroscience Applied 2023 2 Supplement 2
Databáze: ScienceDirect